1. Home
  2. CRVS vs BIOX Comparison

CRVS vs BIOX Comparison

Compare CRVS & BIOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • BIOX
  • Stock Information
  • Founded
  • CRVS 2014
  • BIOX 2001
  • Country
  • CRVS United States
  • BIOX Argentina
  • Employees
  • CRVS N/A
  • BIOX N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • BIOX Agricultural Chemicals
  • Sector
  • CRVS Health Care
  • BIOX Industrials
  • Exchange
  • CRVS Nasdaq
  • BIOX Nasdaq
  • Market Cap
  • CRVS 305.4M
  • BIOX 168.3M
  • IPO Year
  • CRVS 2016
  • BIOX N/A
  • Fundamental
  • Price
  • CRVS $5.75
  • BIOX $2.77
  • Analyst Decision
  • CRVS Strong Buy
  • BIOX Strong Buy
  • Analyst Count
  • CRVS 4
  • BIOX 4
  • Target Price
  • CRVS $15.00
  • BIOX $8.38
  • AVG Volume (30 Days)
  • CRVS 518.7K
  • BIOX 279.5K
  • Earning Date
  • CRVS 08-07-2025
  • BIOX 09-08-2025
  • Dividend Yield
  • CRVS N/A
  • BIOX N/A
  • EPS Growth
  • CRVS N/A
  • BIOX N/A
  • EPS
  • CRVS N/A
  • BIOX N/A
  • Revenue
  • CRVS N/A
  • BIOX $383,289,394.00
  • Revenue This Year
  • CRVS N/A
  • BIOX N/A
  • Revenue Next Year
  • CRVS N/A
  • BIOX $7.30
  • P/E Ratio
  • CRVS N/A
  • BIOX N/A
  • Revenue Growth
  • CRVS N/A
  • BIOX N/A
  • 52 Week Low
  • CRVS $2.54
  • BIOX $2.60
  • 52 Week High
  • CRVS $10.00
  • BIOX $11.39
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 65.10
  • BIOX 35.91
  • Support Level
  • CRVS $5.28
  • BIOX $2.63
  • Resistance Level
  • CRVS $5.64
  • BIOX $2.89
  • Average True Range (ATR)
  • CRVS 0.30
  • BIOX 0.19
  • MACD
  • CRVS 0.03
  • BIOX 0.02
  • Stochastic Oscillator
  • CRVS 77.70
  • BIOX 30.77

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Share on Social Networks: